News
May 13, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medic NewAmsterdam Pharma Company N.V. (NAMS) delivered earnings and revenue surprises of -8.89% and 7.66% ...
MGX stock is soaring Wednesday on the heels of ... Shares are down 67% for the last 12 months and 24% over the last six months. As for Stargate, the project is expected to be a major boost to ...
EMERYVILLE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback